v3.26.3
Condensed Consolidated Statements of (Loss) Income (Unaudited) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 27, 2026
Sep. 28, 2025
Sep. 27, 2026
Sep. 28, 2025
Net sales $ 91.7 $ 95.6 $ 273.1 $ 300.7
Cost of goods sold (69.3) (72.8) (203.7) (231.7)
Gross profit 22.4 22.8 69.4 69.0
Selling, general and administrative expenses (11.8) (11.8) (36.5) (38.3)
Research and development (1.4) (0.9) (4.4) (3.1)
Restructuring charges (0.7) (3.4) (4.5) (5.2)
Disposal related costs (1.0) (1.1) (1.0) (1.2)
Loss on assets held-for-sale 0.0 0.0 0.0 (2.8)
Other costs (4.7) 0.0 (6.5) 0.0
Operating income 2.8 5.6 16.5 18.4
Net interest expense (1.0) (0.7) (2.7) (2.4)
Net defined benefit pension (charge) / credit (0.1) 0.6 (0.2) 1.8
Income before income taxes 1.7 5.5 13.6 17.8
Provision for income taxes (0.8) (2.8) (4.3) (7.0)
Net income $ 0.9 $ 2.7 $ 9.3 $ 10.8
Earnings / (loss) per share        
Basic (in dollars per share) $ 0.03 $ 0.1 $ 0.35 $ 0.41
Diluted (in dollars per share) [1] $ 0.03 $ 0.1 $ 0.34 $ 0.4
Weighted average ordinary shares outstanding        
Basic (in shares) 26,759,526 26,746,390 26,713,500 26,743,059
Diluted (in shares) 27,295,210 27,159,024 27,269,641 27,189,456
[1] The basic and diluted loss per share were the same, as the effect of including potential ordinary shares in the calculation of diluted loss per share would have been antidilutive.